Xtant Medical Holdings, Inc.
XTNT- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001453593
No open-market purchases or sales by Xtant Medical Holdings, Inc. insiders were filed in the last 90 days; 32 institutions reported holding it in 13F filings for Q2 2026, worth $33.8M in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Xtant Medical Holdings, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- −1 vs. Q1 2021
- Shares held
- 82.7M
- +8.21M (+11.0%) vs. Q1 2021
- Total value
- $134.8M
- −$41.0M (−23.3%) vs. Q1 2021
- New holders
- 3
- 4 more added
- Sold out
- 4
- 6 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting XTNT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 32 | $33.8M |
| Q1 2026 | 34 | $45.1M |
| Q4 2025 | 35 | $63.8M |
| Q3 2025 | 30 | $52.0M |
| Q2 2025 | 30 | $59.1M |
| Q1 2025 | 28 | $45.3M |
| Q4 2024 | 30 | $42.8M |
| Q3 2024 | 28 | $66.1M |
| Q2 2024 | 27 | $56.7M |
| Q1 2024 | 33 | $105.7M |
| Q4 2023 | 31 | $101.9M |
| Q3 2023 | 28 | $99.3M |
| Q2 2023 | 19 | $76.0M |
| Q1 2023 | 21 | $52.2M |
| Q4 2022 | 19 | $54.1M |
| Q3 2022 | 18 | $58.8M |
| Q2 2022 | 18 | $41.9M |
| Q1 2022 | 19 | $54.8M |
| Q4 2021 | 22 | $45.2M |
| Q3 2021 | 17 | $89.4M |
| Q2 2021 | 20 | $134.8M |
| Q1 2021 | 21 | $175.8M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Xtant Medical Holdings, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 26 | $0 | 0.00% | −483−94.9% | Reduced |
| Bank of America Corp | 72 | $0 | 0.00% | +6+9.1% | Added |
| Wells Fargo & Company | 28 | $0 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 29 | $0 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 25 | $0 | 0.00% | 00.0% | Unchanged |
| Rockefeller Capital Management L.P. | 120 | $0 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 8,230 | $13.0K | 0.00% | −44,410−84.4% | Reduced |
| Victory Capital Management Inc | 13,526 | $22.0K | 0.00% | +1,013+8.1% | Added |
| Price T Rowe Associates Inc | 15,472 | $25.0K | 0.00% | −12,428−44.5% | Reduced |
| HRT Financial LP | 20,070 | $32.0K | 0.00% | −1,256−5.9% | Reduced |
| Geode Capital Management, LLC | 21,204 | $34.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 22,800 | $37.0K | 0.00% | +22,800 | New |
| BlackRock Inc. | 22,961 | $38.0K | 0.00% | +22,818+15,956.6% | Added |
| Citadel Advisors LLC | 36,531 | $60.0K | 0.00% | −55,442−60.3% | Reduced |
| Virtu Financial LLC | 36,613 | $60.0K | 0.01% | +36,613 | New |
| Vanguard Group Inc | 44,170 | $72.0K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 290,902 | $474.0K | 0.01% | −81,398−21.9% | Reduced |
| Renaissance Technologies LLC | 1,012,000 | $1.65M | 0.00% | +90,229+9.8% | Added |
| Altium Capital Management LP | 8,292,602 | $13.5M | 3.14% | +8,292,602 | New |
| OrbiMed Advisors LLC | 72,873,494 | $118.8M | 1.21% | 00.0% | Unchanged |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −47,559−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −11,786−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −2,951−100.0% | Sold out |
| MBM Wealth Consultants, LLC | 0 | $0 | 0.00% | −33−100.0% | Sold out |